Cite
HARVARD Citation
Bracchi, M. et al. (2021). A phase IV, open-label three-arm study investigating the impact of a combination of tenofovir disoproxil fumarate/emtricitabine with raltegravir or dolutegravir or elvitegravir/cobicistat on renal function in HIV-1 antiretroviral naïve patients. HIV research & clinical practice. 22 (5), pp. 128-139. [Online].